Skip to content

Organon logo

Main menu
      • Our focus
      • Products list
      • Patient support programs
      • Organon Pro for healthcare professionals
      • Safety data sheets
      • Product patents
      • Leadership team
      • Board of Directors
      • Corporate governance
    • Business development
    • Our culture
    • Our stories
    • Policies & positions
    • Environmental, social & governance
      • Our Suppliers
      • Supplier relationship management
    • Media
    • News
    • Investor relations overview
    • Events & presentations
    • SEC filings
    • Financial Information
    • Investor resources
  • Careers

Contact us

Visit Organon's Twitter Opens a new window Visit Organon's Facebook Opens a new window Visit Organon's LinkedIn Opens a new window Visit Organon's Instagram Opens a new window Visit Organon's YouTube Opens a new window

Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:
Investor relations > SEC filings

SEC Filings

Date

Issuer

Type

Description

Download

Date
July 02, 2025

Issuer
SEQUEIRA RAMONA

Type
3

Description
Initial Statement of Beneficial Ownership

Download
Icons / 32 / PDF Created with Sketch.
Icons / 32 / XSLX Created with Sketch.

Date
July 02, 2025

Issuer
SEQUEIRA RAMONA

Type
4

Description
Statement of Changes in Beneficial Ownership

Download
Icons / 32 / PDF Created with Sketch.
Icons / 32 / XSLX Created with Sketch.

Date
June 16, 2025

Issuer
OZUAH PHILIP

Type
4

Description
Statement of Changes in Beneficial Ownership

Download
Icons / 32 / PDF Created with Sketch.
Icons / 32 / XSLX Created with Sketch.

Date
June 16, 2025

Issuer
LEONE DEBORAH R

Type
4

Description
Statement of Changes in Beneficial Ownership

Download
Icons / 32 / PDF Created with Sketch.
Icons / 32 / XSLX Created with Sketch.

Date
June 16, 2025

Issuer
SHARP SHALINI

Type
4

Description
Statement of Changes in Beneficial Ownership

Download
Icons / 32 / PDF Created with Sketch.
Icons / 32 / XSLX Created with Sketch.

Date
June 16, 2025

Issuer
PATTON CYNTHIA M

Type
4

Description
Statement of Changes in Beneficial Ownership

Download
Icons / 32 / PDF Created with Sketch.
Icons / 32 / XSLX Created with Sketch.

Date
June 16, 2025

Issuer
WHITEFORD GRACE PUMA

Type
4

Description
Statement of Changes in Beneficial Ownership

Download
Icons / 32 / PDF Created with Sketch.
Icons / 32 / XSLX Created with Sketch.

Date
June 16, 2025

Issuer
LAZARUS ROCHELLE B

Type
4

Description
Statement of Changes in Beneficial Ownership

Download
Icons / 32 / PDF Created with Sketch.
Icons / 32 / XSLX Created with Sketch.

Date
June 16, 2025

Issuer
GAYLE HELENE D

Type
4

Description
Statement of Changes in Beneficial Ownership

Download
Icons / 32 / PDF Created with Sketch.
Icons / 32 / XSLX Created with Sketch.

Date
June 16, 2025

Issuer
EZEKOWITZ ALAN

Type
4

Description
Statement of Changes in Beneficial Ownership

Download
Icons / 32 / PDF Created with Sketch.
Icons / 32 / XSLX Created with Sketch.

Items per page

1-10 of 49

Organon & Co., Inc. makes no representations or warranties with respect to the information contained herin and takes no responsibility for supplementing, updating, or correcting and such information. You are provided a hyperlink to a third-party SEC filings website Organon & Co., Inc. does not maintain for provide information directly to the site.

SEC Certifications

Woman wearing green hijab and glasses on computer

Sign Up for Email Alerts

Get our latest investor news, updates and other information.

For questions, please contact our team.

Contact Investor Relations

551-430-6900
investor_relations@organon.com

Connect with us on social

Linkedin icon Opens a new window Twitter icon Opens a new window Facebook icon Opens a new window Instagram icon Opens a new window YouTube icon Opens a new window
Organon logo

Company

  • About us
  • Our Leaders
  • Environmental, social & governance
  • Policies & positions

Resources

  • Patient resources
  • Investor relations
  • Media
  • Organon Pro for healthcare professionals

Contact us

  • Contact information
  • Global locations
  • Forward-Looking Statement
  • Cookie policy
  • Privacy Policy
  • Consumer Health Data Policy
  • Terms of Use
  • Sitemap
© 2025 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies. This site is intended for residents of the United States.
Level Access website accessibility icon. Opens a new window TRUSTe Opens a new window

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

Any statements set forth on this website that are not historical facts are considered “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of Organon’s management and are subject to significant risks and uncertainties. By their nature, forward-looking statements involve risks and uncertainties because they depend on circumstances that may or may not occur in the future. Although these statements are based on assumptions that we believe are reasonable when made, we caution you that forward-looking statements are not guarantees of future performance and you should not place undue reliance on them.

Organon undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s other filings with the Securities and Exchange Commission (SEC), including its registration statement on Form 10, available at the SEC’s Internet site (www.sec.gov Opens a new window).

Decline Accept